Atlanta-based Orthopedic and Back Pain Centers of America added The Dallas PRP and Stem Cell Institute to its network.
Biologics
US Stem Cell Clinic under fire after FDA investigation found 'significant deviations' — 5 key points
The FDA issued a warning letter to the Sunrise, Fla.-based US Stem Cell Clinic for inaccurate marketing of its stem cell products as well as other deviations, according to the FDA.
Regenerative Biologics Institute opened the doors of its new facility in Vero Beach, Fla.
Here are 16 points on spinal fusions.
Boise, Idaho-based Burst Biologics will begin a study involving spinal fusion patients.
Huntley, Ill.-based Life Spine reported record revenue growth of 424 percent in the past fiscal year for its biologics product line.
Bone Biologics Corp. reported the addition of osteoporosis and trauma indications to its portfolio.
The global spine biologics market will grow through 2024, based on a Transparency Market Research report, according to medGadget.
Four spine surgeons discuss trends in the use of spine biologics.
The global spine biologics market is predicted to exceed more than $2.5 billion by 2022 with a growth rate of 4.4 percent, Finance Wire reports.
